| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Capricor Therapeutics Inc (NASDAQ: CAPR)
CAPR Technical Analysis
4
| As on 9th Jun 2023 CAPR STOCK Price closed @ 4.70 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.35 & Strong Buy for SHORT-TERM with Stoploss of 3.68 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CAPRSTOCK Price
| Open | 4.60 | Change | Price | % |
| High | 4.81 | 1 Day | 0.12 | 2.62 |
| Low | 4.60 | 1 Week | 0.17 | 3.75 |
| Close | 4.70 | 1 Month | 0.82 | 21.13 |
| Volume | 85300 | 1 Year | 1.54 | 48.73 |
| 52 Week High 6.55 | 52 Week Low 2.83 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CAPR Daily Charts |
CAPR Intraday Charts |
Whats New @ Bazaartrend |
CAPR Free Analysis |
|
|
CAPR Important Levels Intraday
| RESISTANCE | 5.10 |
| RESISTANCE | 4.97 |
| RESISTANCE | 4.89 |
| RESISTANCE | 4.81 |
| SUPPORT | 4.59 |
| SUPPORT | 4.51 |
| SUPPORT | 4.43 |
| SUPPORT | 4.30 |
CAPR Forecast April 2024
| 4th UP Forecast | 9.04 |
| 3rd UP Forecast | 7.65 |
| 2nd UP Forecast | 6.79 |
| 1st UP Forecast | 5.93 |
| 1st DOWN Forecast | 3.47 |
| 2nd DOWN Forecast | 2.61 |
| 3rd DOWN Forecast | 1.75 |
| 4th DOWN Forecast | 0.36 |
CAPR Weekly Forecast
| 4th UP Forecast | 5.84 |
| 3rd UP Forecast | 5.47 |
| 2nd UP Forecast | 5.25 |
| 1st UP Forecast | 5.02 |
| 1st DOWN Forecast | 4.38 |
| 2nd DOWN Forecast | 4.15 |
| 3rd DOWN Forecast | 3.93 |
| 4th DOWN Forecast | 3.56 |
CAPR Forecast2024
| 4th UP Forecast | 12.45 |
| 3rd UP Forecast | 9.96 |
| 2nd UP Forecast | 8.43 |
| 1st UP Forecast | 6.89 |
| 1st DOWN Forecast | 2.51 |
| 2nd DOWN Forecast | 0.97 |
| 3rd DOWN Forecast | -0.56 |
| 4th DOWN Forecast | -3.05 |
Capricor Therapeutics Inc ( NASDAQ USA Symbol : CAPR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CAPR Business Profile
Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase II clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with COVID-19; and completed various trials investigating the use of CAP-1002 for the treatment of cardiac conditions, including heart failure and post myocardial infarction with cardiac dysfunction. It is also developing CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in preclinical stage for the potential prevention of COVID-19. Capricor collaborates with Lonza Houston, Inc. for the development of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in Beverly Hills, California. Address: 8840 Wilshire Boulevard, Beverly Hills, CA, United States, 90211
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service